Health carers providing support to individuals requiring an inhaler or nebuliser need to know how to use, monitor and assess inhaler technique effectively.
Introduction
'Confidential Inquiry into the Deaths of People with Learning Disability (CIPOLD)' recommended that adults with LD to be considered a high-risk group for deaths from respiratory problems. Having the insight of the additional challenges these health problems present for individuals with a LD who are already a known to be a high-risk group experiencing co-morbidities arising from long-term conditions (Public Health England (PHE) 2016) is of paramount importance for the health carer. In achieving a therapeutic goal promoting self-care and independence (Aldridge 2010) it is important to involve the individual with LD in the choice of inhaler and select a device they find easy to use (Davis, 2016) . 'Reasonable adjustments' (Equality Act 2010; PHE 2017) should be anticipated, the individual with a LD may require additional support and guidance to select their device and develop an effective technique; 'Patient friendly' monitoring can help manage symptoms (Stothard, 2017) . The individual is likely to benefit from familiarisation/desensitisation to the equipment and procedures, preparation is likely to reduce the individual's anxiety or fear and increase positive outcomes for all involved.
Inhalers are one the most common medication prescribed in the United Kingdom (UK), the Prescription Cost Analysis (NHS Digital 2017) states that over £1 billion is spent on the respiratory system medication alone, with inhalers making the largest percentage of money spent on this system. Beclometasone dipropionate (a corticosteroid inhaler) accounting for the most amount of money the National Health Service (NHS) England spends on a single drug, costing over £174 Million a year (NHS Digital 2017) . Two of the most common diseases that require inhalers and nebulisers for treatment include asthma and Chronic Obstructive Pulmonary Disease (COPD). Currently around 5.4 million people are receiving treatment for asthma in the UK (Asthma UK 2018) and an estimated 1.2 million are diagnosed with COPD in the UK British Lung Foundation (BLS) (2018) . A significant percentage of people with asthma and COPD will also have a LD as Mencap (2013) reports that 1.5 million people have a LD within the UK, an estimated 2% of the UK population.
A report by Allan et al (2012) highlights individuals with LD who smoke are twice as likely to have asthma and more than half of women with LD and asthma also have associated problems with obesity (a risk factor for poorly controlled asthma). The report (Allan et al 2012) also indicates that respiratory disease is the leading cause of death for people with LD and is responsible for around half of all deaths among people with LD this is much higher than for the general population diagnosed with respiratory disease.
It has been highly reported that people with LD experience significant health inequalities compared to the general population, with higher levels of unmet needs PHE (2016) delays in access to diagnosis, investigations or specialist referrals (Mencap 2007 (Mencap , 2012 resulting in a higher incidence of untimely deaths (Mencap 2012; Heslop et.al 2013; PHE 2016) .
According to Price et.al. (2013) 
Metered Dose Inhalers (MDI)
MDI are the most common type of inhaler (Image A) used in practice and often the cheapest method of delivering the medication (Joint Formulary Committee, 2018) . MDI dispense medication through an aerosol spray or mist, through each push of a canister a measured dose of medication is produced (Perry, Potter & Elkin 2012) . This type of inhaler requires a degree of dexterity as the individual needs to be able to inhale at the same time the medication is being delivered (canister is pushed) (Lynes 2007) . The individual needs to ensure that they are inhaling slowly and deeply to ensure that the drug goes to the peripheral airways instead of the mouth or throat (Capstick & Clifton 2012) . They also need to understand the importance of following this process correctly in order to optimise the medication delivery. Inhalers need to be cleaned regularly following the manufactures instructions.
Image A

Example of MDI
Time out 2
Please watch this short video on how to take a MDI, this will help to reinforce the information you have read. Asthma UK (2012) How to take a Metered Dose Inhaler https://youtu.be/FqztOZLqFhE As you view the video consider how you would explain and demonstrate this technique to an individual with LD.
Identify any reasonable adjustments which may be required (see Box 1).
Identify the role of the family carer, how this might differ from that of a paid carer?
Breath-Actuated Inhaler (BAI)
Breath-Actuated Inhaler (BAI) see (Image B) is a different form of the MDI. The medication comes in an aerosol canister however this is not visible, and the individual cannot push the canister down. When the patient inhalers a mechanism automatically realises the drug, this means inhalation and actuation coincide with each other (Currie 2011) . This is useful as the dexterity is not as essential, as with the MDI, however the individual still needs to focus on the strength of inhalation to ensure it reaches the lungs adequately (Newman et al. 1991) .
BAI have been demonstrated to improve the deposition of aerosol within the lungs for patients who have difficulty coordinating Inhalation when previously using MDI (Capstick & Clifton 2012) . A slow and steady inhalation is still required to ensure optimisation of medication.
It may be worth considering swapping to this form of inhaler if the individual is finding the MDI challenging.
This form of inhaler is much more expensive than the MDI (Joint Formulary Committee, 2018).
Image B
An example of a BAI inhaler
Time out 3
Please watch these two short videos on how to take two different types of BDI, to help reinforce the information you have read.
Asthma UK (2012) How to take an Easi-Breathe inhaler -https://youtu.be/Qf-yHFEq8lU Asthma UK (2012) How to take an Autohaler -https://youtu.be/5q7FpntKnm8
As you view these videos consider how you would explain and demonstrate these techniques to an individual with LD.
Dry Powder Inhalers (DPI)
DPI (Images C, D, E, F,) medication comes in a dry powder different to that of the MDI. The main advantage of DPI is that they do not require coordinated activation (Bonni & Usmani 2015) . Therefore, use is similar to that of the BAI. The mechanism of the inhaler works differently to the BAI.
The major differences to that of the MDI are that in order for this type of inhaler to work effectively, the medication needs to be inhaled quickly and deeply and the medication needs to be made active by the individual in order for it to be delivered. DPI requires much higher inhalation flows than MDI, and not using a forceful and deep inspiration is a common critical issue with DPI (Bonni & Usmani 2015) . Depending on the type of DPI activating the medication may involve twisting, clicking or manually adding the medication to the inhaler.
The variation in techniques may cause some additional confusion to the individual with a LD (especially if using different types of DPI & MDI). The medication is drawn out of the blister or capsule by the user's inhalation, so individuals will need to be able to take a quick and deep breath in to pull the medication out of the carrier (Scullion 2017) .
For this type of inhaler, the medication is often more expensive compared to the MDI (Joint Formulary Committee, 2018).
Image C
Single dose of DPI inhaler (example)
Image D, E, F,
Multi-dose DPI inhalers (example)
Time out 4
Please watch these two short videos on how to take two different types of DPI. This will to help reinforce the information you have read.
Asthma UK (2012) How to take an Accuhaler inhaler https://youtu.be/0mgggfL0zjw
Asthma UK (2012) How to take an Turbohaler inhaler https://youtu.be/2_6DvPwZj2s
Revisit 'Time out 2'
Additional Equipment
Additional equipment can be attached to inhalers to help improve technique and efficacy, for instance a lever can be added for individuals who struggle to push the aerosol down (MDI). These are often added for individuals who have a physical condition such as rheumatoid arthritis.
Additional assessment devices are also available that can help ascertain if the individual is inhaling too softly or too strongly; this equipment can be useful to help promote the correct strength of inhalation for the individual using a MDI. Placebo inhalers are also available to help assess and improve technique and can be useful when training and assessing (Image G); a lack of placebo inhalers in clinical practice is often a barrier to provide adequate inhaler technique training GOLD (2018).
Image G
Placebo MDI inhaler
Spacers can also be added if an individual has poor coordination when using a MDI inhaler.
As part of the assessment process it is necessary to understand and utilise these additional equipment pieces as it will help to improve optimisation of the medication.
Spacers
Spacers (Images H, I, J, K,) are useful if an individual has poor dexterity or difficulty with the coordination when using a MDI. A spacer may be a useful additional equipment piece and is often used with children, the elderly and people with physical disability or LD (Sanchis et.al 2016) .
The medication is delivered into a valued chamber acting as a temporary reservoir before inhalation this helps to slow the delivery of the medication (White 2015) . The medication is delivered into the spacer and the individual does not need to focus on inhalation at the same time as the canister being pushed, thus reducing the coordination required. There are also two different breathing techniques (single breath or multiple breaths) that can be used with a spacer however this still requires a slow and steady inhalation; the individual may find one breathing technique easier than the other. Certain brands of spacer will whistle if the inhalation is too quick, this audible reference may be useful when promoting successful inhaler technique. A mask is sometimes added to the spacer if the individual lacks the coordination to make a seal around the inhaler mouthpiece. This is often used with young children and again maybe suitable to consider with individuals with LD. Spacers need to be cleaned regularly according to the manufactories recommendation.
Image H, I, J, K.
Types of spacers.
Volumatic AeroChamber Plus Able Spacer
Antistatic holding chamber
Time out 5
Please watch these short videos on how to use a spacer including different breathing techniques and using them on children, to help reinforce the information you have read. Nebuliser Nebulisers can be used through a compressor (Image L), an ultra-sonic or through piped O2 or air (often only available in secondary care). Nebulisers use oxygen, compressed air or ultrasonic power to break up medical solutions into fine aerosol mist that can be directly inhaled from the mouthpiece/mask Curie (2011). A nebuliser normally takes around 5-10 minutes (British Thoracic Society (BTS) 1997; NICE 2018) however it can be challenging to determine when to stop the nebuliser. Informing the user that nebulisation therapy usually continues until the volume left in the nebuliser is so low that the nebuliser ceases to function continuously and begins to "splutter" (Boe et al 2001) this is the sign to turn the nebuliser off. Often used in more acute settings, nebulisers often use the same drug as an inhaler but at larger dosages, if an Individuals unable to coordinate an inhaler effectively and medication that is required that is only available via this route i.e. nebulised antibiotics (Blackler, Jones & Mooney, 2007) .
If an individual does not have the dexterity to take an inhaler a nebuliser may be the only option available. However, currently there is no evidence that shows nebuliser therapy is superior to inhalers if inhalers are used correctly (GOLD 2018) . According to Davis (2016) , nebulisers should be prescribed to individuals with LD with social/visual attentiveness deficits or for whom inhalers have proved unsuccessful. However their previous study (Davis et al 2015) found that paid care givers didn't believe they have had appropriate training in the use of nebulisers. It is therefore imperative that carers are provided with appropriate training and support individuals in the correct usage of their nebuliser.
Nebulisers can be delivered though a mouthpiece or face-mask (Image M & N). Face masks are used more frequently used in secondary care if the patient is acutely ill as it is more likely to ensure the patient receives the medication.
According to Kelly and Lynes (2011) research has shown that the nebuliser equipment is often not cleaned correctly after use resulting in bacteria growing within them. This will put the patient at direct risk of respiratory infections as the contaminated vapour will be breathed directly into the lungs. Therefore, cleaning the equipment adequately after use is an essential part of the process. This process involves cleaning with warm soapy water and being left to air dry, and it should be performed at least daily if the nebulisers are used regularly (Kelly and Lynes 2011) Nebulisers also require to be serviced regally to ensure their effectiveness. Identify any reasonable adjustments which may be required (see Box 1).
Image L
Inhaler technique
Below is a basic 7 steps technique checklist (Table 1) . This is relevant to all inhalers types. This is a simple and easy checklist to follow when teaching/assessing inhaler technique and can be used for both MDI & DPI. However, the type of inhalation is different depending on whether the inhaler is a MDI or DPI. Inhaler technique checklist 1. Prepare the device (e.g. remove the mouthpiece cover, open the device, hold the inhaler upright) 2. Prepare the dose (e.g. shake all aerosols and load dose for DPIs) 3. Breathe out gently as far as is comfortable (not into inhalers) 4. Put the mouthpiece in the mouth and close the lips around it 5. Breathe in: Check co-ordination of breathing and actuation of MDI Think about the type of inhaler device -is it an aerosol device or DPI? Breathe in slowly and steadily for all aerosol devices (including through a spacer device). Breathe in quickly and deeply for all DPIs 6. Remove inhaler from the mouth and hold breath for ten seconds 7. Repeat dose (if applicable), replace mouthpiece cover or close device. (Murphy 2016, p.9) 
Annual Reviews
In order to determine if an inhaler/nebuliser is being taken effectively it is essential that this is reviewed and monitored correctly. This assessment/review is usually undertaken by a practice nurse during a yearly review of the condition for example within an Asthma/COPD clinic and forms part of the individuals 'Annual Health Check' (NHS England, 2017; Royal College of General Practitioners (RCGP) n.d.). NICE (2013) quality standard stipulates that an individual with asthma receives a structured review each year. However, despite yearly assessment the individual often reverts back to poor inhaler technique within a short period of time (Price et.al. 2013) . This poor practice is likely to be more prevalent with individuals with a LD where retention of information regarding technique and dexterity in the skills is compromised. To assist with support and continuity of care it is imperative that the intervention is clearly and accurately recorded in the individual's health action plan (RCGP n.d.) . The nurse can help to promote adequate inhaler technique, and this is a vital part of the yearly review. Please see the table below (Table 2) for some common inhaler errors to be aware of. Exhaling into the mouth piece after inhalation (Chrystyn & Price, 2009) According to Stothard (2017) 
Time out 7
Read the article by Price et al (2013) Answer the following from this case study: (You may find it beneficial to review some of the resources and your responses during your time out activities). 
Conclusion
Individuals with LD experience significant health inequalities compared to the general population with higher levels of unmet needs and delays in access to diagnosis, investigations or specialist referrals (Heslop et.al. 2013; PHE, 2016) . With recent high-profile cases highlighting that individuals' having a long-term condition alongside a LD the care is often substandard (Heslop et.al.2013; MENCAP 2013; PHE 2016) . The need to ensure effective inhaler technique is paramount. It is essential as a nurse supporting an individual with a LD to have the knowledge and understanding of how inhalers are used, assessed and monitored correctly, coinciding with the NMC code. This will help to ensure optimisation of the medication thus helping to reduce clinical symptoms, improve QoL and reduce the need to attend primary and secondary care services (GINA 2108 & GOLD 2018 .
By reading and carrying out the tasks & case study in this article the reader will understand how to deliver an inhaler correctly for MDI, DPI and nebulisers. The reader will have insight into the additional challengers this skill requires for individuals with LD. The reader will be able to assess and monitor inhaler technique accordingly and consider when additional equipment or change of inhaler type might help improve optimisation of the medication.
Box 1 Reasonable adjustments
Reasonable adjustments:
Public Health England (2017) Reasonable adjustments: a legal duty (Guidance) [Online] Available from: https://www.gov.uk/government/publications/reasonable-adjustmentsfor-people-with-learning-disabilities/reasonable-adjustments-a-legal-duty NHS England (no date) Reasonable adjustments [Online] . Available from: https://www.england.nhs.uk/learning-disabilities/improving-health/reasonableadjustments/ Asthma UK -Easy read resourceshttps://www.asthma.org.uk/advice/resources/#easyread Explore the resources in this site and review them for use in your own practice think about how you will share these resources with your colleagues.
What 'Easy Read' resources do you have available for use in your practice area?
What equipment will you require to demonstrate technique?
Try using the term "easy read" to search for other online resources.
